Matches in Nanopublications for { ?s ?p "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP307850.RAeFOkVwds3ACpG36VjORe_KQVTg1Z0lJZyfUKWbd9QD8130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307850.RAeFOkVwds3ACpG36VjORe_KQVTg1Z0lJZyfUKWbd9QD8130_provenance.
- NP906998.RAXt6j_wLJ7KDh2SN5IbgR1OJSN_WGhELsIsbKZxvvB4E130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906998.RAXt6j_wLJ7KDh2SN5IbgR1OJSN_WGhELsIsbKZxvvB4E130_provenance.
- assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP306543.RAmHRBoa-KLSbA9XqD9iUa3iNHjJ9ZiFeAqMzbiFFnGO4130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306543.RAmHRBoa-KLSbA9XqD9iUa3iNHjJ9ZiFeAqMzbiFFnGO4130_provenance.
- NP1305722.RArdSAN3mFCQJm9UaJer56bKsp7bAiAVHlY-24ZlCAszg130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305722.RArdSAN3mFCQJm9UaJer56bKsp7bAiAVHlY-24ZlCAszg130_provenance.
- NP1305725.RAsgMwX-dypUmjr0MixhaJNXUJg3dU3Wwc70JvD5_IdZA130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305725.RAsgMwX-dypUmjr0MixhaJNXUJg3dU3Wwc70JvD5_IdZA130_provenance.
- NP392712.RA6qU6K7KkIJ1ECV2ivZE-mMOKyWA7-o9aBHgmMl2M0BU130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392712.RA6qU6K7KkIJ1ECV2ivZE-mMOKyWA7-o9aBHgmMl2M0BU130_provenance.
- NP669036.RAP_QMZ_xa4H8UMHmfx6gHvKsvyKPlI8_G6AnVrzUWgHA130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669036.RAP_QMZ_xa4H8UMHmfx6gHvKsvyKPlI8_G6AnVrzUWgHA130_provenance.
- NP1305726.RANXVxKD_YwHqaJ_eEQF-gKECA9QBR1P7hZn6cohmt3Kc130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305726.RANXVxKD_YwHqaJ_eEQF-gKECA9QBR1P7hZn6cohmt3Kc130_provenance.
- NP1305730.RA9EIeUhu254KHleeqgXE-XLED8rTZ4pctS6LmtHG0Nis130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305730.RA9EIeUhu254KHleeqgXE-XLED8rTZ4pctS6LmtHG0Nis130_provenance.
- NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_provenance.